AGC Biologics is set to expand its Cell Line Development Centre of Excellence through a partnership with ATUM.

Citizen Health has entered a multi-year strategic partnership with UCB for expediting drug development across five rare ...

Patient advocacy and industry bodies welcomed the bill’s backing, though it will now need to be passed in the Senate.

New non-primate draft guidance follows the FDA's wider aim to curtail the use of animal testing in preclinical toxicology.

Rare disease research faces complex regulations, small patient populations, and high costs. As traditional incentives wane, ...

Biotechs in the charter city of Próspera aim to cure ageing, but experts question the feasibility of their goals.

Data management in oncology clinical trials features multiple complexities, and choosing the right EDC system is essential.

The World Health Organization (WHO) predicts that fewer than 10% of eligible patients will have access to GLP-1RAs by 2030.

With $1.5 billion in drug sales, the US dominated the CKD-HPT, HP and HK market in 2024, representing 59.7% of 7MM sales.

As 2026 approaches, rising complexity, geopolitical pressures and new modalities are reshaping strategy, capacity and CDMO ...

The UK becomes the latest country in President Donald Trump’s long line of trade agreements, though it is the first region to ...

If approved, Regeneron and Tessera's TSRA-196 could become the first curative therapy to reach patients with AATD, who have ...